{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T20:03:38Z","timestamp":1786565018145,"version":"build-2736575974"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08179-x","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:17:00Z","timestamp":1777025820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesenchymal stem cells for recurrent miscarriage"],"prefix":"10.1186","volume":"24","author":[{"given":"Famela S.","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Veltmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Koumjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dede","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"1","key":"8179_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12948-015-0015-y","volume":"13","author":"MP Piccinni","year":"2015","unstructured":"Piccinni MP, Lombardelli L, Logiodice F, Kullolli O, Romagnani S, Le Bouteiller P. T helper cell mediated-tolerance towards fetal allograft in successful pregnancy. Clin Mol Allergy. 2015;13(1):9. https:\/\/doi.org\/10.1186\/s12948-015-0015-y.","journal-title":"Clin Mol Allergy"},{"issue":"1","key":"8179_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jri.2010.01.006","volume":"85","author":"MP Piccinni","year":"2010","unstructured":"Piccinni MP. T cell tolerance towards the fetal allograft. J Reprod Immunol. 2010;85(1):71\u201375. https:\/\/doi.org\/10.1016\/j.jri.2010.01.006.","journal-title":"J Reprod Immunol"},{"issue":"1","key":"8179_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jri.2012.08.004","volume":"97","author":"E Seppanen","year":"2013","unstructured":"Seppanen E, Fisk NM, Khosrotehrani K. Pregnancy-acquired fetal progenitor cells. J Reprod Immunol. 2013;97(1):27\u201335. https:\/\/doi.org\/10.1016\/j.jri.2012.08.004.","journal-title":"J Reprod Immunol"},{"issue":"2","key":"8179_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/clinchem\/hvaa304","volume":"67","author":"DW Bianchi","year":"2021","unstructured":"Bianchi DW, Khosrotehrani K, Way SS, MacKenzie TC, Bajema I, O\u2019Donoghue K. Forever connected: the lifelong biological consequences of Fetomaternal and maternofetal microchimerism. Clin Chem. 2021;67(2):351\u201362. https:\/\/doi.org\/10.1093\/clinchem\/hvaa304.","journal-title":"Clin Chem"},{"issue":"7","key":"8179_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.placenta.2006.10.006","volume":"28","author":"C Vernochet","year":"2007","unstructured":"Vernochet C, Caucheteux SM, Kanellopoulos-Langevin C. Bi-directional cell trafficking between mother and fetus in mouse placenta. Placenta. 2007;28(7):639\u201349. https:\/\/doi.org\/10.1016\/j.placenta.2006.10.006.","journal-title":"Placenta"},{"key":"8179_CR6","doi-asserted-by":"publisher","unstructured":"Magnus MC, Wilcox AJ, Morken N-H, Weinberg CR, H\u00e5berg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. https:\/\/doi.org\/10.1136\/bmj.l869.","DOI":"10.1136\/bmj.l869"},{"key":"8179_CR7","doi-asserted-by":"publisher","first-page":"657552","DOI":"10.3389\/fimmu.2021.657552","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu H, Lin X-X, Huang X-B, Huang D-H, Song S, Chen Y-J, et al. Systemic Characterization of novel immune cell phenotypes in recurrent pregnancy loss. Front Immunol. 2021;12:657552. https:\/\/doi.org\/10.3389\/fimmu.2021.657552.","journal-title":"Front Immunol"},{"key":"8179_CR8","doi-asserted-by":"publisher","first-page":"1634430","DOI":"10.3389\/fimmu.2025.1634430","volume":"16","author":"JC Morgan","year":"2025","unstructured":"Morgan JC, Hynes GE, Pollard JM, Andrade MS, Jeong JC, Chong AS. Hyporesponsive fetus-specific T cell responses in multiparous human pregnancy. Front Immunol. 2025;16:1634430. https:\/\/doi.org\/10.3389\/fimmu.2025.1634430.","journal-title":"Front Immunol"},{"key":"8179_CR9","doi-asserted-by":"publisher","unstructured":"Li Z, Si P, Meng T, Zhao X, Zhu C, Zhang D, et al. CCR8 + decidual regulatory T cells maintain maternal-fetal immune tolerance during early pregnancy. Sci Immunol. 2025;10(106):eado 2463. https:\/\/doi.org\/10.1126\/sciimmunol.ado2463.","DOI":"10.1126\/sciimmunol.ado2463"},{"key":"8179_CR10","doi-asserted-by":"publisher","unstructured":"Hosking SL, Moldenhauer LM, Tran HM, Chan HY, Groome HM, Lovell EAK, et al. Treg cells promote decidual vascular remodeling and modulate uterine NK cells in pregnant mice. JCI Insight. 2025;10(2). https:\/\/doi.org\/10.1172\/jci.insight.169836.","DOI":"10.1172\/jci.insight.169836"},{"issue":"6","key":"8179_CR11","doi-asserted-by":"publisher","first-page":"104756","DOI":"10.1016\/j.rbmo.2024.104756","volume":"50","author":"C Mai","year":"2025","unstructured":"Mai C, Yamamoto M, Shibahara H, Wang Q, Fukui A. Higher CD16-NKp46bright uterine endometrial natural killer cells may predict pregnancy success in women experiencing recurrent reproductive failure. Reprod Biomed Online. 2025;50(6):104756. https:\/\/doi.org\/10.1016\/j.rbmo.2024.104756.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"8179_CR12","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/08820139.2021.1909061","volume":"51","author":"Y Yousefzadeh","year":"2022","unstructured":"Yousefzadeh Y, Soltani-Zangbar MS, Hemmatzadeh M, Shomali N, Mahmoodpoor A, Ahmadian Heris J, et al. Fetomaternal immune tolerance: crucial mechanisms of tolerance for successful pregnancy in humans. Immunol Invest. 2022;51(4):1108\u201325. https:\/\/doi.org\/10.1080\/08820139.2021.1909061.","journal-title":"Immunol Invest"},{"issue":"6","key":"8179_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1600-0897.2010.00810.x","volume":"63","author":"JE Thaxton","year":"2010","unstructured":"Thaxton JE, Sharma S. Review article: interleukin-10: a multi-faceted agent of pregnancy. Am J Rep Immunol. 2010;63(6):482\u201391. https:\/\/doi.org\/10.1111\/j.1600-0897.2010.00810.x.","journal-title":"Am J Rep Immunol"},{"issue":"6","key":"8179_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1600-0897.2008.00582.x","volume":"59","author":"DA Clark","year":"2008","unstructured":"Clark DA, Fernandez J, Banwatt D. Original article: prevention of spontaneous abortion in the CBA \u00d7 DBA\/2 mouse model by intravaginal TGF-\u03b2 and local recruitment of CD4 + 8 + FOXP3 + cells. Am J Rep Immunol. 2008;59(6):525\u201334. https:\/\/doi.org\/10.1111\/j.1600-0897.2008.00582.x.","journal-title":"Am J Rep Immunol"},{"issue":"193","key":"8179_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.24976\/Discov.Med.202537193.22","volume":"37","author":"L Peng","year":"2025","unstructured":"Peng L, Yang M, Luo X. Silencing TGF-\u03b23 alleviates recurrent spontaneous abortion inflammation in mice: the importance of Treg\/Th17 cell balance. Discov Med. 2025;37(193):276\u201385. https:\/\/doi.org\/10.24976\/Discov.Med.202537193.22.","journal-title":"Discov Med"},{"key":"8179_CR16","doi-asserted-by":"publisher","unstructured":"Park JS, Song A-Y, Bae J-Y, Han JW, Kim TH, Kim C-J, et al. IL-17 producing T to Foxp3 + CD4 + regulatory T cell ratio as a diagnostic and prognostic Marker in women with recurrent pregnancy loss and its implications for Intravenous immunoglobulin therapy. Am J Rep Immunol. 2024;92(5):e70020. https:\/\/doi.org\/10.1111\/aji.70020.","DOI":"10.1111\/aji.70020"},{"issue":"5","key":"8179_CR17","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.fertnstert.2007.08.043","volume":"90","author":"M Jerzak","year":"2008","unstructured":"Jerzak M, Kniotek M, Mrozek J, G\u00f3rski A, Baranowski W. Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriage. Fertil Steril. 2008;90(5):1848\u201353. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.08.043.","journal-title":"Fertil Steril"},{"issue":"1","key":"8179_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-0897.2012.01135.x","volume":"68","author":"M Moraru","year":"2012","unstructured":"Moraru M, Carbone J, Alecsandru D, Castillo-Rama M, Garc\u00eda-Segovia A, Gil J, et al. Intravenous immunoglobulin treatment increased live birth rate in a S panish cohort of women with recurrent reproductive failure and expanded CD 56 + cells. Am J Rep Immunol. 2012;68(1):75\u201384. https:\/\/doi.org\/10.1111\/j.1600-0897.2012.01135.x.","journal-title":"Am J Rep Immunol"},{"issue":"2","key":"8179_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF02390365","volume":"249","author":"P Mallmann","year":"1991","unstructured":"Mallmann P, Mallmann R, Krebs D. Determination of tumor necrosis factor alpha (TNF\u03b1) and Interleukin 2 (IL2) in women with idiopathic recurrent miscarriage. Arch Gynecol Obstet. 1991;249(2):73\u201378. https:\/\/doi.org\/10.1007\/BF02390365.","journal-title":"Arch Gynecol Obstet"},{"key":"8179_CR20","unstructured":"Rezaei A, Dabbagh A. T-helper (1) cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion. Med Sci Monit. 2002;8(8):CR607\u201310."},{"issue":"4","key":"8179_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/humrep\/deg156","volume":"18","author":"JY Kwak-Kim","year":"2003","unstructured":"Kwak-Kim JY, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reproduction. 2003;18(4):767\u201373. https:\/\/doi.org\/10.1093\/humrep\/deg156.","journal-title":"Hum Reproduction"},{"issue":"2","key":"8179_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/molehr\/gah013","volume":"10","author":"DA Clark","year":"2004","unstructured":"Clark DA, et al. The fgl2 prothrombinase\/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction. Mol Hum Reprod. 2004;10(2):99\u2013108. https:\/\/doi.org\/10.1093\/molehr\/gah013.","journal-title":"Mol Hum Reprod"},{"issue":"5","key":"8179_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.tjog.2019.07.007","volume":"58","author":"J Fu","year":"2019","unstructured":"Fu J, Li L, Qi L, Zhao L. A randomized controlled trial of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders. Taiwan J Obstet Gynecol. 2019;58(5):621\u201325. https:\/\/doi.org\/10.1016\/j.tjog.2019.07.007.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"8179_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/ETLS20200042","volume":"4","author":"DA Clark","year":"2020","unstructured":"Clark DA. On use of animal models. Emerging Top Life Sci. 2020;4(2):207\u201327. https:\/\/doi.org\/10.1042\/ETLS20200042.","journal-title":"Emerging Top Life Sci"},{"issue":"1","key":"8179_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/aji.12437","volume":"75","author":"WM Xu","year":"2016","unstructured":"Xu WM, Xiao Z-N, Wang X-B, Huang Y. IL -17 induces fetal loss in a CBA \/J\u00d7 BALB \/c mouse model, and an anti- IL -17 antibody prevents fetal loss in a CBA \/J \u00d7 DBA \/2 mouse model. Am J Rep Immunol. 2016;75(1):51\u201358. https:\/\/doi.org\/10.1111\/aji.12437.","journal-title":"Am J Rep Immunol"},{"key":"8179_CR26","doi-asserted-by":"publisher","first-page":"104744","DOI":"10.1016\/j.jri.2025.104744","volume":"172","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jin L, Gan B, Zheng S, Zhao X, Wei J. The role of mTOR signaling pathway-mediated Treg\/Th17 cell imbalance in recurrent spontaneous abortion. J Reprod Immunol. 2025;172:104744. https:\/\/doi.org\/10.1016\/j.jri.2025.104744.","journal-title":"J Reprod Immunol"},{"key":"8179_CR27","doi-asserted-by":"publisher","unstructured":"Li M, Sun F, Qian J, Chen L, Li D, Wang S, et al. Tim-3\/CTLA-4 pathways regulate decidual immune cells-extravillous trophoblasts interaction by IL-4 and IL-10. The FASEB J. 2021;35(8):e21754. https:\/\/doi.org\/10.1096\/fj.202100142R.","DOI":"10.1096\/fj.202100142R"},{"issue":"2","key":"8179_CR28","doi-asserted-by":"publisher","first-page":"111513","DOI":"10.1016\/j.yexcr.2019.111513","volume":"383","author":"J Liu","year":"2019","unstructured":"Liu J, Chen X, Hao S, Zhao H, Pang L, Wang L, et al. Human chorionic gonadotropin and IL-35 contribute to the maintenance of peripheral immune tolerance during pregnancy through mediating the generation of IL-10+ or IL-35+ Breg cells. Exp Cell Res. 2019;383(2):111513. https:\/\/doi.org\/10.1016\/j.yexcr.2019.111513.","journal-title":"Exp Cell Res"},{"issue":"3","key":"8179_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1600-0897.1997.tb00225.x","volume":"37","author":"PC Arck","year":"1997","unstructured":"Arck PC, Clark DA, Troutt AB. Soluble receptors neutralizing TNF-\u03b1 and IL-1 block stress-triggered murine abortion. Am J Rep Immunol. 1997;37(3):262\u201366. https:\/\/doi.org\/10.1111\/j.1600-0897.1997.tb00225.x.","journal-title":"Am J Rep Immunol"},{"issue":"2","key":"8179_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0897.2009.00774.x","volume":"63","author":"DA Clark","year":"2010","unstructured":"Clark DA, Chaouat G, Wong K, Gorczynski RM, Kinsky R. Review article: tolerance mechanisms in pregnancy: a reappraisal of the role of class I paternal MHC Antigens*. Am J Rep Immunol. 2010;63(2):93\u2013103. https:\/\/doi.org\/10.1111\/j.1600-0897.2009.00774.x.","journal-title":"Am J Rep Immunol"},{"issue":"9","key":"8179_CR31","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s10815-022-02582-1","volume":"39","author":"M Kurokawa","year":"2022","unstructured":"Kurokawa M, Takeshita A, Hashimoto S, Koyama M, Morimoto Y, Tachibana D. Prevention of intrauterine fetal growth restriction by administrating C1q\/TNF-related protein 6, a specific inhibitor of the alternative complement pathway. J Assist Reprod Genet. 2022;39(9):2191\u201399. https:\/\/doi.org\/10.1007\/s10815-022-02582-1.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"8179_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-0897.2008.00605.x","volume":"60","author":"G Yu","year":"2008","unstructured":"Yu G, Sun Y, Foerster K, Manuel J, Molina H, Levy GA, et al. Original article: LPS-Induced murine abortions require C5 but not C3, and are prevented by upregulating expression of the CD200 tolerance signaling molecule. Am J Rep Immunol. 2008;60(2):135\u201340. https:\/\/doi.org\/10.1111\/j.1600-0897.2008.00605.x.","journal-title":"Am J Rep Immunol"},{"issue":"12","key":"8179_CR33","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.4049\/jimmunol.1501361","volume":"195","author":"M Petitbarat","year":"2015","unstructured":"Petitbarat M, Durigutto P, Macor P, Bulla R, Palmioli A, Bernardi A, et al. Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating. J Immunol. 2015;195(12):5602\u201307. https:\/\/doi.org\/10.4049\/jimmunol.1501361.","journal-title":"J Immunol"},{"issue":"1","key":"8179_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3727\/096368910X","volume":"20","author":"DC Ding","year":"2011","unstructured":"Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transpl. 2011;20(1):5\u201314. https:\/\/doi.org\/10.3727\/096368910X.","journal-title":"Cell Transpl"},{"issue":"12","key":"8179_CR35","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/sctm.17-0129","volume":"6","author":"RM Samsonraj","year":"2017","unstructured":"Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, Van Wijnen AJ, Cool SM. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. STEM Cells Transl Med. 2017;6(12):2173\u201385. https:\/\/doi.org\/10.1002\/sctm.17-0129.","journal-title":"STEM Cells Transl Med"},{"key":"8179_CR36","doi-asserted-by":"publisher","first-page":"1421854","DOI":"10.3389\/fimmu.2024.1421854","volume":"15","author":"R Mei","year":"2024","unstructured":"Mei R, Wan Z, Yang C, Shen X, Wang R, Zhang H, et al. Advances and clinical challenges of mesenchymal stem cell therapy. Front Immunol. 2024;15:1421854. https:\/\/doi.org\/10.3389\/fimmu.2024.1421854.","journal-title":"Front Immunol"},{"issue":"10","key":"8179_CR37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.5966\/sctm.2012-0034","volume":"1","author":"M Shi","year":"2012","unstructured":"Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. STEM Cells Transl Med. 2012;1(10):725\u201331. https:\/\/doi.org\/10.5966\/sctm.2012-0034.","journal-title":"STEM Cells Transl Med"},{"issue":"10","key":"8179_CR38","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/liv.12228","volume":"33","author":"M Mohamadnejad","year":"2013","unstructured":"Mohamadnejad M, Alimoghaddam K, Bagheri M, Ashrafi M, Abdollahzadeh L, Akhlaghpoor S, et al. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int. 2013;33(10):1490\u201396. https:\/\/doi.org\/10.1111\/liv.12228.","journal-title":"Liver Int"},{"issue":"3","key":"8179_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/scrt459","volume":"5","author":"H Salama","year":"2014","unstructured":"Salama H, Zekri A-RN, Medhat E, Al Alim SA, Ahmed OS, Bahnassy AA, et al. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease. STEM Cell Res Ther. 2014;5(3):70. https:\/\/doi.org\/10.1186\/scrt459.","journal-title":"STEM Cell Res Ther"},{"issue":"1","key":"8179_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman AW, DiFede DL, Fishman JE, Zambrano JP, Trachtenberg BH, Karantalis V, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2014;311(1):62\u201373. https:\/\/doi.org\/10.1001\/jama.2013.282909.","journal-title":"JAMA"},{"issue":"27","key":"8179_CR41","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","volume":"36","author":"AB Mathiasen","year":"2015","unstructured":"Mathiasen AB, Qayyum AA, J\u00f8rgensen E, Helqvist S, Fischer-Nielsen A, Kofoed KF, et al. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J. 2015;36(27):1744\u201353. https:\/\/doi.org\/10.1093\/eurheartj\/ehv136.","journal-title":"Eur Heart J"},{"issue":"2","key":"8179_CR42","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.4238\/2015.April.10.11","volume":"14","author":"XF Zhao","year":"2015","unstructured":"Zhao XF, Xu Y, Zhu ZY, Gao CY, Shi YN. Clinical observation of umbilical cord mesenchymal stem cell treatment of severe systolic heart failure. Genet Mol Res. 2015;14(2):3010\u201317. https:\/\/doi.org\/10.4238\/2015.April.10.11.","journal-title":"Genet Mol Res"},{"issue":"6","key":"8179_CR43","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1161\/CIRCRESAHA.115.306332","volume":"117","author":"EC Perin","year":"2015","unstructured":"Perin EC, Borow KM, Silva GV, DeMaria AN, Marroquin OC, Huang PP, et al. A Phase II dose-escalation study of allogeneic mesenchymal Precursor cells in patients with ischemic or Nonischemic heart failure. Circ Res. 2015;117(6):576\u201384. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306332.","journal-title":"Circ Res"},{"issue":"3","key":"8179_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12265-016-9686-0","volume":"9","author":"K Anastasiadis","year":"2016","unstructured":"Anastasiadis K, Antonitsis P, Westaby S, Reginald A, Sultan S, Doumas A, et al. Implantation of a novel allogeneic mesenchymal precursor cell type in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting: an open label Phase IIa trial. J Cardiovasc Trans Res. 2016;9(3):202\u201313. https:\/\/doi.org\/10.1007\/s12265-016-9686-0.","journal-title":"J Cardiovasc Trans Res"},{"issue":"8","key":"8179_CR45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/CIRCRESAHA.116.309281","volume":"119","author":"KE Hatzistergos","year":"2016","unstructured":"Hatzistergos KE, Saur D, Seidler B, Balkan W, Breton M, Valasaki K, et al. Stimulatory effects of mesenchymal stem cells on cKit+ cardiac stem cells are mediated by SDF1\/CXCR4 and SCF\/cKit signaling pathways. Circ Res. 2016;119(8):921\u201330. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309281.","journal-title":"Circ Res"},{"issue":"5","key":"8179_CR46","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","volume":"69","author":"JM Hare","year":"2017","unstructured":"Hare JM, DiFede DL, Rieger AC, Florea V, Landin AM, El-Khorazaty J, et al. Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial. J Am Coll Cardiol. 2017;69(5):526\u201337. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.009.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"8179_CR47","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1161\/CIRCRESAHA.116.309717","volume":"120","author":"J Butler","year":"2017","unstructured":"Butler J, Epstein SE, Greene SJ, Quyyumi AA, Sikora S, Kim RJ, et al. Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a Phase II-A randomized trial. Circ Res. 2017;120(2):332\u201340. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309717.","journal-title":"Circ Res"},{"issue":"4","key":"8179_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10557-018-6804-z","volume":"32","author":"SH Kim","year":"2018","unstructured":"Kim SH, Cho JH, Lee YH, Lee JH, Kim SS, Kim MY, et al. Improvement in left ventricular function with intracoronary mesenchymal stem cell therapy in a patient with anterior wall ST-Segment elevation myocardial infarction. Cardiovasc Drugs Ther. 2018;32(4):329\u201338. https:\/\/doi.org\/10.1007\/s10557-018-6804-z.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"12","key":"8179_CR49","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/jama.2019.2341","volume":"321","author":"TM Yau","year":"2019","unstructured":"Yau TM, Pagani FD, Mancini DM, Chang HL, Lala A, Woo YJ, et al. Intramyocardial injection of mesenchymal precursor cells and successful temporary weaning from left ventricular assist device support in patients with advanced heart failure: a randomized clinical trial. JAMA. 2019;321(12):1176\u201386. https:\/\/doi.org\/10.1001\/jama.2019.2341.","journal-title":"JAMA"},{"issue":"7","key":"8179_CR50","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1253\/circj.CJ-18-1179","volume":"83","author":"T Yagyu","year":"2019","unstructured":"Yagyu T, Yasuda S, Nagaya N, Doi K, Nakatani T, Satomi K, et al. Long-term results of intracardiac mesenchymal stem cell transplantation in patients with Cardiomyopathy. Circ J. 2019;83(7):1590\u201399. https:\/\/doi.org\/10.1253\/circj.CJ-18-1179.","journal-title":"Circ J"},{"issue":"5","key":"8179_CR51","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/ejhf.1700","volume":"22","author":"AB Mathiasen","year":"2020","unstructured":"Mathiasen AB, Qayyum AA, J\u00f8rgensen E, Helqvist S, Kofoed KF, Haack-S\u00f8rensen M, et al. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial. Eur J Heart Fail. 2020;22(5):884\u201392. https:\/\/doi.org\/10.1002\/ejhf.1700.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"8179_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13287-024-03713-4","volume":"15","author":"ZT Ahmed","year":"2024","unstructured":"Ahmed ZT, Zain Al-Abeden MS, Al Abdin MG, Muqresh MA, Al Jowf GI, Eijssen LMT, et al. Dose-response relationship of MSCs as living Bio-drugs in HFrEF patients: a systematic review and meta-analysis of RCTs. STEM Cell Res Ther. 2024;15(1):165. https:\/\/doi.org\/10.1186\/s13287-024-03713-4.","journal-title":"STEM Cell Res Ther"},{"key":"8179_CR53","first-page":"106694","volume-title":"Mesenchymal stem cells in clinical trials for multiple sclerosis: a systematic literature review and review of clinical trials","author":"MA Nahayati","year":"2025","unstructured":"Nahayati MA, et al. Mesenchymal stem cells in clinical trials for multiple sclerosis: a systematic literature review and review of clinical trials. Vol. 103. Mult Scler Relat Disord; 2025. p. 106694."},{"key":"8179_CR54","first-page":"963689724123304","volume-title":"Human umbilical cord-derived mesenchymal stem cells in the treatment of multiple sclerosis patients: phase I\/II dose-finding clinical study","author":"F Jamali","year":"2024","unstructured":"Jamali F, et al. Human umbilical cord-derived mesenchymal stem cells in the treatment of multiple sclerosis patients: phase I\/II dose-finding clinical study. Cell Transplant. 2024;33:p. 9636897241233045."},{"key":"8179_CR55","first-page":"104895","volume-title":"Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I\/IIa, double blind, randomized controlled study","author":"SM Nabavi","year":"2023","unstructured":"Nabavi SM, et al. Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I\/IIa, double blind, randomized controlled study. Vol. 78. Mult Scler Relat Disord; 2023. p. 104895."},{"key":"8179_CR56","doi-asserted-by":"publisher","first-page":"639315","DOI":"10.3389\/fneur.2021.639315","volume":"12","author":"P Petrou","year":"2021","unstructured":"Petrou P, Kassis I, Ginzberg A, Halimi M, Yaghmour N, Abramsky O, et al. Long-term clinical and immunological effects of repeated mesenchymal stem cell injections in patients with progressive forms of multiple sclerosis. Front Neurol. 2021;12:639315. https:\/\/doi.org\/10.3389\/fneur.2021.639315.","journal-title":"Front Neurol"},{"issue":"12","key":"8179_CR57","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1093\/brain\/awaa333","volume":"143","author":"P Petrou","year":"2020","unstructured":"Petrou P, Kassis I, Levin N, Paul F, Backner Y, Benoliel T, et al. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain. 2020;143(12):3574\u201388. https:\/\/doi.org\/10.1093\/brain\/awaa333.","journal-title":"Brain"},{"issue":"1","key":"8179_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13287-025-04184-x","volume":"16","author":"L Zeng","year":"2025","unstructured":"Zeng L, Liu C, Wu Y, Liu S, Zheng Y, Hao W, et al. Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials. STEM Cell Res Ther. 2025;16(1):65. https:\/\/doi.org\/10.1186\/s13287-025-04184-x.","journal-title":"STEM Cell Res Ther"},{"issue":"12","key":"8179_CR59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/17460751.2024.2443352","volume":"19","author":"A Jamshidi","year":"2024","unstructured":"Jamshidi A, Beheshti Maal A, Alikhani M, Madani H, Sadri B, Moghaddassi M, et al. Allogeneic bone marrow derived clonal mesenchymal stromal cells in refractory rheumatoid arthritis: a pilot study. Regen Med. 2024;19(12):599\u2013609. https:\/\/doi.org\/10.1080\/17460751.2024.2443352.","journal-title":"Regen Med"},{"key":"8179_CR60","doi-asserted-by":"publisher","unstructured":"Mesa LE, L\u00f3pez JG, L\u00f3pez Quiceno L, Barrios Arroyave F, Halpert K, Camacho JC, et al. Safety and efficacy of mesenchymal stem cells therapy in the treatment of rheumatoid arthritis disease: a systematic review and meta-analysis of clinical trials. PLoS One. 2023;18(7):e0284828. https:\/\/doi.org\/10.1371\/journal.pone.0284828.","DOI":"10.1371\/journal.pone.0284828"},{"issue":"8","key":"8179_CR61","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00125-023-05934-3","volume":"66","author":"PO Carlsson","year":"2023","unstructured":"Carlsson PO, Espes D, Sisay S, Davies LC, Smith CIE, Svahn MG. Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I\/II randomised double-blind placebo-controlled trial. Diabetologia. 2023;66(8):1431\u201341. https:\/\/doi.org\/10.1007\/s00125-023-05934-3.","journal-title":"Diabetologia"},{"issue":"1","key":"8179_CR62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-022-02941-w","volume":"13","author":"M Izadi","year":"2022","unstructured":"Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, et al. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I\/II randomized placebo-controlled clinical trial. STEM Cell Res Ther. 2022;13(1):264. https:\/\/doi.org\/10.1186\/s13287-022-02941-w.","journal-title":"STEM Cell Res Ther"},{"issue":"4","key":"8179_CR63","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jcyt.2021.09.015","volume":"24","author":"Z Wu","year":"2022","unstructured":"Wu Z, Xu X, Cai J, Chen J, Huang L, Wu W, et al. Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up. Cytotherapy. 2022;24(4):421\u201327. https:\/\/doi.org\/10.1016\/j.jcyt.2021.09.015.","journal-title":"Cytotherapy"},{"key":"8179_CR64","doi-asserted-by":"publisher","first-page":"102688","DOI":"10.1016\/j.mtbio.2025.102688","volume":"36","author":"X Zhang","year":"2026","unstructured":"Zhang X, Lin Z, Lv M, Lu C, Hu B, Yu W, et al. Cartilage organoids bridging bench to bedside: a steroid-free strategy for early osteoarthritis repair. Mater Today Bio. 2026;36:102688. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102688.","journal-title":"Mater Today Bio"},{"key":"8179_CR65","doi-asserted-by":"publisher","unstructured":"Patel RJ, Manfre MG, Stokes DJ, Dragoo JL. Adipose-derived therapies for the treatment of knee osteoarthritis: do They work and are They safe? Clin Sports Med. Clinics Sports Med. 2025;44(4):699\u2013720. https:\/\/doi.org\/10.1016\/j.csm.2025.01.006.","DOI":"10.1016\/j.csm.2025.01.006"},{"issue":"11","key":"8179_CR66","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/gerona\/glx137","volume":"72","author":"BA Tompkins","year":"2017","unstructured":"Tompkins BA, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, et al. Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci. 2017;72(11):1513\u201322. https:\/\/doi.org\/10.1093\/gerona\/glx137.","journal-title":"The Journals Gerontology Ser A"},{"key":"8179_CR67","first-page":"246","volume-title":"Mesenchymal stem cell therapy attenuates complement C3 deposition and improves the delicate equilibrium between angiogenic and anti-angiogenic factors in abortion-prone mice","author":"S Shahgaldi","year":"2022","unstructured":"Shahgaldi S, Kahmini FR, Moazzeni SM. Mesenchymal stem cell therapy attenuates complement C3 deposition and improves the delicate equilibrium between angiogenic and anti-angiogenic factors in abortion-prone mice. Vol. 141. Mol Immunol; 2022. p. 246\u201356."},{"key":"8179_CR68","doi-asserted-by":"publisher","unstructured":"Perez JA, Parcero Valdes JJ, Corral Moreno R, Gomez Cuevas LI, Lopez JJ, Ichim T, et al. Intravenous administration of umbilical cord-derived mesenchymal stem cells (UC-MSC) for acute respiratory distress syndrome due to COVID-19 infection. Cureus. 2023;15(8):e44110. https:\/\/doi.org\/10.7759\/cureus.44110.","DOI":"10.7759\/cureus.44110"},{"issue":"10","key":"8179_CR69","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.4252\/wjsc.v12.i10.1067","volume":"12","author":"F Lin","year":"2020","unstructured":"Lin F, Ichim TE, Pingle S, Jones LD, Kesari S, Ashili S. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome. WJSC. 2020;12(10):1067\u201379. https:\/\/doi.org\/10.4252\/wjsc.v12.i10.1067.","journal-title":"WJSC"},{"issue":"6","key":"8179_CR70","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/ALN.0000000000001882","volume":"127","author":"C Keane","year":"2017","unstructured":"Keane C, Jerkic M, Laffey JG. Stem cell\u2013based therapies for sepsis. Anesthesiology. 2017;127(6):1017\u201334. https:\/\/doi.org\/10.1097\/ALN.0000000000001882.","journal-title":"Anesthesiology"},{"issue":"4","key":"8179_CR71","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jcyt.2025.01.005","volume":"27","author":"KL Blanc","year":"2025","unstructured":"Blanc KL, Dazzi F, English K, Farge D, Galipeau J, Horwitz EM, et al. ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells. Cytotherapy. 2025;27(4):413\u201316. https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.005.","journal-title":"Cytotherapy"},{"issue":"6","key":"8179_CR72","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1089\/scd.2011.0157","volume":"21","author":"E Svobodova","year":"2012","unstructured":"Svobodova E, Krulova M, Zajicova A, Pokorna K, Prochazkova J, Trosan P, et al. The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population. STEM Cells Devel. 2012;21(6):901\u201310. https:\/\/doi.org\/10.1089\/scd.2011.0157.","journal-title":"STEM Cells Devel"},{"issue":"1","key":"8179_CR73","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/cells10010058","volume":"10","author":"A Fiori","year":"2021","unstructured":"Fiori A, Uhlig S, Kl\u00fcter H, Bieback K. Human adipose tissue-derived mesenchymal stromal cells inhibit CD4+ T cell proliferation and induce regulatory T cells as well as CD127 expression on CD4+CD25+ T cells. Cells. 2021;10(1):58. https:\/\/doi.org\/10.3390\/cells10010058.","journal-title":"Cells"},{"issue":"12","key":"8179_CR74","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/TP.0b013e3181fed001","volume":"90","author":"W Ge","year":"2010","unstructured":"Ge W, Jiang J, Arp J, Liu W, Garcia B, Wang H. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2, 3-dioxygenase expression. Transplantation. 2010;90(12):1312\u201320. https:\/\/doi.org\/10.1097\/TP.0b013e3181fed001.","journal-title":"Transplantation"},{"issue":"6","key":"8179_CR75","doi-asserted-by":"publisher","first-page":"664","DOI":"10.5009\/gnl18072","volume":"12","author":"H Jo","year":"2018","unstructured":"Jo H, Eom YW, Kim H-S, Park HJ, Kim HM, Cho M-Y. Regulatory dendritic cells induced by mesenchymal stem cells ameliorate dextran sodium sulfate-induced chronic colitis in mice. Gut Liver. 2018;12(6):664\u201373. https:\/\/doi.org\/10.5009\/gnl18072.","journal-title":"Gut Liver"},{"issue":"2","key":"8179_CR76","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3109\/08820139.2011.607877","volume":"41","author":"ZG Zhao","year":"2012","unstructured":"Zhao ZG, Xu W, Sun L, You Y, Li F, Li Q-B, et al. Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol Invest. 2012;41(2):183\u201398. https:\/\/doi.org\/10.3109\/08820139.2011.607877.","journal-title":"Immunol Invest"},{"issue":"3","key":"8179_CR77","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.4049\/jimmunol.170.3.1304","volume":"170","author":"WP Min","year":"2003","unstructured":"Min WP, Zhou D, Ichim TE, Strejan GH, Xia X, Yang J, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol. 2003;170(3):1304\u201312. https:\/\/doi.org\/10.4049\/jimmunol.170.3.1304.","journal-title":"J Immunol"},{"issue":"6","key":"8179_CR78","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/humupd\/dml004","volume":"12","author":"H Achache","year":"2006","unstructured":"Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reproduction Update. 2006;12(6):731\u201346. https:\/\/doi.org\/10.1093\/humupd\/dml004.","journal-title":"Hum Reproduction Update"},{"issue":"4","key":"8179_CR79","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1071\/RD14208","volume":"28","author":"E Menkhorst","year":"2016","unstructured":"Menkhorst E, Winship A, Van Sinderen M, Dimitriadis E. Human extravillous trophoblast invasion: intrinsic and extrinsic regulation. Reprod Fertil Dev. 2016;28(4):406\u201315. https:\/\/doi.org\/10.1071\/RD14208.","journal-title":"Reprod Fertil Dev"},{"issue":"5","key":"8179_CR80","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/cmi.2014.44","volume":"11","author":"PD Lima","year":"2014","unstructured":"Lima PD, Tu MM, Rahim MMA, Peng AR, Croy BA, Makrigiannis AP. Ly49 receptors activate angiogenic mouse DBA+ uterine natural killer cells. Cell Mol Immunol. 2014;11(5):467\u201376. https:\/\/doi.org\/10.1038\/cmi.2014.44.","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"8179_CR81","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/emmm.201302618","volume":"5","author":"M Kim","year":"2013","unstructured":"Kim M, Park HJ, Seol JW, Jang JY, Cho Y-S, Kim KR, et al. VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy. EMBO Mol Med. 2013;5(9):1415\u201330. https:\/\/doi.org\/10.1002\/emmm.201302618.","journal-title":"EMBO Mol Med"},{"key":"8179_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/393707","volume":"2014","author":"X Gong","year":"2014","unstructured":"Gong X, Chen Z, Liu Y, Lu Q, Jin Z. Gene expression profiling of the paracrine effects of uterine natural killer cells on human endometrial epithelial cells. Int J Endocrinol. 2014;2014:1\u201315. https:\/\/doi.org\/10.1155\/2014\/393707.","journal-title":"Int J Endocrinol"},{"key":"8179_CR83","doi-asserted-by":"publisher","unstructured":"Ratsep MT, Felker AM, Kay VR, Tolusso L, Hofmann AP, Croy BA. Uterine natural killer cells: supervisors of vasculature construction in early decidua basalis. Reproduction. 2015;149(2):R91\u2013102. https:\/\/doi.org\/10.1530\/REP-14-0271.","DOI":"10.1530\/REP-14-0271"},{"issue":"3","key":"8179_CR84","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1189\/jlb.0406250","volume":"80","author":"GE Lash","year":"2006","unstructured":"Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol. 2006;80(3):572\u201380. https:\/\/doi.org\/10.1189\/jlb.0406250.","journal-title":"J Leukoc Biol"},{"issue":"12","key":"8179_CR85","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1096\/fj.12-210310","volume":"26","author":"A Robson","year":"2012","unstructured":"Robson A, Harris LK, Innes BA, Lash GE, Aljunaidy MM, Aplin JD, et al. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. The FASEB J. 2012;26(12):4876\u201385. https:\/\/doi.org\/10.1096\/fj.12-210310.","journal-title":"The FASEB J"},{"issue":"6","key":"8179_CR86","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.4049\/jimmunol.171.6.2937","volume":"171","author":"AA Ashkar","year":"2003","unstructured":"Ashkar AA, Black GP, Wei Q, He H, Liang L, Head JR, et al. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol. 2003;171(6):2937\u201344. https:\/\/doi.org\/10.4049\/jimmunol.171.6.2937.","journal-title":"J Immunol"},{"issue":"4","key":"8179_CR87","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/humupd\/dmaa062","volume":"27","author":"I Diaz-Hernandez","year":"2021","unstructured":"Diaz-Hernandez I, Alecsandru D, Garc\u00eda-Velasco JA, Dom\u00ednguez F. Uterine natural killer cells: from foe to friend in reproduction. Hum Reproduction Update. 2021;27(4):720\u201346. https:\/\/doi.org\/10.1093\/humupd\/dmaa062.","journal-title":"Hum Reproduction Update"},{"issue":"6","key":"8179_CR88","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1189\/jlb.0604337","volume":"76","author":"RH McIntire","year":"2004","unstructured":"McIntire RH, Morales PJ, Petroff MG, Colonna M, Hunt JS. Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-\u03b21. J Leukoc Biol. 2004;76(6):1220\u201328. https:\/\/doi.org\/10.1189\/jlb.0604337.","journal-title":"J Leukoc Biol"},{"issue":"4","key":"8179_CR89","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-0897.2007.00469.x","volume":"57","author":"WH Yan","year":"2007","unstructured":"Yan WH, Lin A, Chen B-G, Zhou M-Y, Dai M-Z, Chen X-J, et al. Possible roles of KIR2DL4 expression on uNK cells in human pregnancy. Am J Rep Immunol. 2007;57(4):233\u201342. https:\/\/doi.org\/10.1111\/j.1600-0897.2007.00469.x.","journal-title":"Am J Rep Immunol"},{"issue":"1","key":"8179_CR90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/cells13010059","volume":"13","author":"A Wasilewska","year":"2023","unstructured":"Wasilewska A, Grabowska M, Moskalik-Kierat D, Brzoza M, Lauda\u0144ski P, Garley M. Immunological aspects of infertility\u2014the role of KIR receptors and HLA-C antigen. Cells. 2023;13(1):59. https:\/\/doi.org\/10.3390\/cells13010059.","journal-title":"Cells"},{"key":"8179_CR91","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.placenta.2024.02.009","volume":"149","author":"M Bora","year":"2024","unstructured":"Bora M, Singha S, Madan T, Deka G, Hazarika SG, Baruah S. HLA-G isoforms, HLA-C allotype and their expressions differ between early abortus and placenta in relation to spontaneous abortions. Placenta. 2024;149:44\u201353. https:\/\/doi.org\/10.1016\/j.placenta.2024.02.009.","journal-title":"Placenta"},{"key":"8179_CR92","doi-asserted-by":"publisher","first-page":"104310","DOI":"10.1016\/j.jri.2024.104310","volume":"165","author":"M Cozzolino","year":"2024","unstructured":"Cozzolino M, Pellegrini L, Tartaglia S, Mancuso S, De Angelis F, Vaquero E, et al. Subcutaneous G-CSF administration improves IVF outcomes in patients with recurrent implantation failure presenting a KIR\/HLA-C mismatch. J Reprod Immunol. 2024;165:104310. https:\/\/doi.org\/10.1016\/j.jri.2024.104310.","journal-title":"J Reprod Immunol"},{"issue":"5","key":"8179_CR93","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1007\/s43032-022-01110-x","volume":"30","author":"M Nurzadeh","year":"2023","unstructured":"Nurzadeh M, Ghalandarpoor-Attar SM, Ghalandarpoor-Attar SN, Rabiei M. The role of interferon (IFN)-\u03b3 in extravillous trophoblast cell (EVT) invasion and preeclampsia progression. Reprod. Sci. 2023;30(5):1462\u201369. https:\/\/doi.org\/10.1007\/s43032-022-01110-x.","journal-title":"Reprod. Sci"},{"issue":"7","key":"8179_CR94","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1089\/scd.2013.0473","volume":"23","author":"F Ogura","year":"2014","unstructured":"Ogura F, Wakao S, Kuroda Y, Tsuchiyama K, Bagheri M, Heneidi S, et al. Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. STEM Cells Devel. 2014;23(7):717\u201328. https:\/\/doi.org\/10.1089\/scd.2013.0473.","journal-title":"STEM Cells Devel"},{"issue":"9","key":"8179_CR95","first-page":"1781","volume":"6","author":"Y Wang","year":"2013","unstructured":"Wang Y, Xu B, Li M-Q, Li D-J, Jin L-P. IL-22 secreted by decidual stromal cells and NK cells promotes the survival of human trophoblasts. Int J Clin Exp Pathol. 2013;6(9):1781\u201390.","journal-title":"Int J Clin Exp Pathol"},{"key":"8179_CR96","doi-asserted-by":"publisher","first-page":"821542","DOI":"10.3389\/fimmu.2022.821542","volume":"13","author":"X Du","year":"2022","unstructured":"Du X, Zhu H, Jiao D, Nian Z, Zhang J, Zhou Y, et al. Human-induced CD49a+ NK cells promote fetal growth. Front Immunol. 2022;13:821542. https:\/\/doi.org\/10.3389\/fimmu.2022.821542.","journal-title":"Front Immunol"},{"issue":"6","key":"8179_CR97","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1046\/j.8755-8920.2003.00112.x","volume":"50","author":"C Lidstrom","year":"2003","unstructured":"Lidstrom C, Matthiesen L, Berg G, Sharma S, Ernerudh J, Ekerfelt C. Cytokine secretion patterns of NK cells and macrophages in early human pregnancy decidua and blood: implications for suppressor macrophages in decidua. Am J Rep Immunol. 2003;50(6):444\u201352. https:\/\/doi.org\/10.1046\/j.8755-8920.2003.00112.x.","journal-title":"Am J Rep Immunol"},{"issue":"5","key":"8179_CR98","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/1933719107314065","volume":"15","author":"RH McIntire","year":"2008","unstructured":"McIntire RH, Ganacias KG, Hunt JS. Programming of human monocytes by the uteroplacental environment. Reprod. Sci. 2008;15(5):437\u201347. https:\/\/doi.org\/10.1177\/1933719107314065.","journal-title":"Reprod. Sci"},{"issue":"3","key":"8179_CR99","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1933719109349962","volume":"17","author":"T Nagamatsu","year":"2010","unstructured":"Nagamatsu T, Schust DJ. The immunomodulatory roles of macrophages at the maternal\u2014fetal interface. Reprod. Sci. 2010;17(3):209\u201318. https:\/\/doi.org\/10.1177\/1933719109349962.","journal-title":"Reprod. Sci"},{"key":"8179_CR100","doi-asserted-by":"publisher","unstructured":"Kaito Y, Ino H, Horii Y, Watanabe A, Nishigaki M, Kubota Y, et al. Prophylactic treatment with progesterone decreases murine miscarriage by suppressing the immunostimulatory activity of macrophages. Mol Hum Reprod. 2025;31(4). https:\/\/doi.org\/10.1093\/molehr\/gaaf050.","DOI":"10.1093\/molehr\/gaaf050"},{"issue":"7","key":"8179_CR101","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.4049\/jimmunol.1100130","volume":"187","author":"J Svensson","year":"2011","unstructured":"Svensson J, Jenmalm MC, Matussek A, Geffers R, Berg G, Ernerudh J. Macrophages at the fetal\u2013maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. J Immunol. 2011;187(7):3671\u201382. https:\/\/doi.org\/10.4049\/jimmunol.1100130.","journal-title":"J Immunol"},{"issue":"1","key":"8179_CR102","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1365-2567.2004.01869.x","volume":"112","author":"DA Somerset","year":"2004","unstructured":"Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004;112(1):38\u201343. https:\/\/doi.org\/10.1111\/j.1365-2567.2004.01869.x.","journal-title":"Immunology"},{"issue":"13","key":"8179_CR103","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.2741\/2840","volume":"13","author":"JR Wilczynski","year":"2008","unstructured":"Wilczynski JR. The characterization and role of regulatory T cells in immune reactions. Front Biosci. 2008;13(13):2266\u201374. https:\/\/doi.org\/10.2741\/2840.","journal-title":"Front Biosci"},{"key":"8179_CR104","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jri.2018.12.002","volume":"131","author":"J Wang","year":"2019","unstructured":"Wang J, Yang J, Yan Y, Zhu Z, Mu Y, Wang X, et al. Effect of adoptive transfer of CD4+CD25+Foxp3+ Treg induced by trichostatin a on the prevention of spontaneous abortion. J Reprod Immunol. 2019;131:30\u201335. https:\/\/doi.org\/10.1016\/j.jri.2018.12.002.","journal-title":"J Reprod Immunol"},{"key":"8179_CR105","doi-asserted-by":"publisher","unstructured":"Cuff AO, Von Woon E, Bainton T, Browne B, Kirkwood PM, Collins F, et al. Dynamic roles of ILC3 in endometrial repair and regeneration. Discov Immunol. 2025;4(1):kyaf004. https:\/\/doi.org\/10.1093\/discim\/kyaf004.","DOI":"10.1093\/discim\/kyaf004"},{"issue":"2","key":"8179_CR106","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1084\/jem.20131038","volume":"211","author":"N Serafini","year":"2014","unstructured":"Serafini N, Klein Wolterink RGJ, Satoh-Takayama N, Xu W, Vosshenrich CAJ, Hendriks RW, et al. Gata3 drives development of ROR\u03b3t+ group 3 innate lymphoid cells. J Exp Med. 2014;211(2):199\u2013208. https:\/\/doi.org\/10.1084\/jem.20131038.","journal-title":"J Exp Med"},{"key":"8179_CR107","doi-asserted-by":"publisher","first-page":"104128","DOI":"10.1016\/j.jri.2023.104128","volume":"159","author":"S Liu","year":"2023","unstructured":"Liu S, Zhang S, Hong L, Diao L, Cai S, Yin T, et al. Characterization of progesterone-induced dendritic cells in metabolic and immunologic reprogramming. J Reprod Immunol. 2023;159:104128. https:\/\/doi.org\/10.1016\/j.jri.2023.104128.","journal-title":"J Reprod Immunol"},{"key":"8179_CR108","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2020.02025","volume":"11","author":"W Wang","year":"2020","unstructured":"Wang W, Sung N, Gilman-Sachs A, Kwak-Kim J. T helper (th) cell profiles in pregnancy and recurrent pregnancy losses: Th1\/Th2\/Th9\/Th17\/Th22\/Tfh cells. Front Immunol. 2020;11:2025. https:\/\/doi.org\/10.3389\/fimmu.2020.02025.","journal-title":"Front Immunol"},{"issue":"1","key":"8179_CR109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4049\/jimmunol.171.1.37","volume":"171","author":"EM Barber","year":"2003","unstructured":"Barber EM, Pollard JW. The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a listeria monocytogenes infection. J Immunol. 2003;171(1):37\u201346. https:\/\/doi.org\/10.4049\/jimmunol.171.1.37.","journal-title":"J Immunol"},{"issue":"3","key":"8179_CR110","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1642-431X(12)60012-6","volume":"8","author":"FW Bazer","year":"2008","unstructured":"Bazer FW, Burghardt RC, Johnson GA, Spencer TE, Wu G. Interferons and progesterone for establishment and maintenance of pregnancy: interactions among novel cell signaling pathways. Reprod Biol. 2008;8(3):179\u2013211. https:\/\/doi.org\/10.1016\/S1642-431X(12)60012-6.","journal-title":"Reprod Biol"},{"issue":"2","key":"8179_CR111","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/humupd\/dmt040","volume":"20","author":"G Barrientos","year":"2014","unstructured":"Barrientos G, Freitag N, Tirado-Gonz\u00e1lez I, Unverdorben L, Jeschke U, Thijssen VLJL, et al. Involvement of galectin-1 in reproduction: past, present and future. Hum Reproduction Update. 2014;20(2):175\u201393. https:\/\/doi.org\/10.1093\/humupd\/dmt040.","journal-title":"Hum Reproduction Update"},{"issue":"21","key":"8179_CR112","doi-asserted-by":"publisher","first-page":"13382","DOI":"10.3390\/ijms232113382","volume":"23","author":"HM Wu","year":"2022","unstructured":"Wu HM, Chen L-H, Hsu L-T, Lai C-H. Immune tolerance of embryo implantation and pregnancy: the role of human decidual stromal cell- and Embryonic-derived extracellular vesicles. IJMS. 2022;23(21):13382. https:\/\/doi.org\/10.3390\/ijms232113382.","journal-title":"IJMS"},{"key":"8179_CR113","doi-asserted-by":"publisher","unstructured":"Taylor SK, Houshdaran S, Robinson JF, Gormley MJ, Kwan EY, Kapidzic M, et al. Cytotrophoblast extracellular vesicles enhance decidual cell secretion of immune modulators via TNF-alpha. Development. 2020;147(17). https:\/\/doi.org\/10.1242\/dev.187013.","DOI":"10.1242\/dev.187013"},{"key":"8179_CR114","doi-asserted-by":"publisher","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Electronic address, a.A.o,. definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2020;113(3):533\u201335. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.11.025.","DOI":"10.1016\/j.fertnstert.2019.11.025"},{"issue":"3","key":"8179_CR115","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/ijms26031295","volume":"26","author":"JV Garmendia","year":"2025","unstructured":"Garmendia JV, De Sanctis CV, Hajd\u00fach M, De Sanctis JB. Exploring the immunological aspects and treatments of recurrent pregnancy loss and recurrent implantation failure. IJMS. 2025;26(3):1295. https:\/\/doi.org\/10.3390\/ijms26031295.","journal-title":"IJMS"},{"issue":"2","key":"8179_CR116","first-page":"76","volume":"2","author":"HB Ford","year":"2009","unstructured":"Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009;2(2):76\u201383.","journal-title":"Rev Obstet Gynecol"},{"key":"8179_CR117","doi-asserted-by":"publisher","first-page":"1722080","DOI":"10.3389\/fimmu.2025.1722080","volume":"16","author":"G Ma","year":"2025","unstructured":"Ma G, Han J, Gao R, Qin L. Immune-mediated mechanisms and maternal-fetal interface dysfunction in obstetric antiphospholipid syndrome. Front Immunol. 2025;16:1722080. https:\/\/doi.org\/10.3389\/fimmu.2025.1722080.","journal-title":"Front Immunol"},{"issue":"5","key":"8179_CR118","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/ard-2023-224930","volume":"83","author":"C Lu","year":"2024","unstructured":"Lu C, Gao R, Qing P, Zeng X, Liao X, Cheng M, et al. Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome. Ann Rheumatic Dis. 2024;83(5):624\u201337. https:\/\/doi.org\/10.1136\/ard-2023-224930.","journal-title":"Ann Rheumatic Dis"},{"key":"8179_CR119","doi-asserted-by":"publisher","unstructured":"Scher J, Dabao C, Rukat C. Thyroid Autoimmunity: the treatment of Hashimoto\u2019s disease, or the presence of antithyroid antibodies alone, in pregnancy. Am J Rep Immunol. 2025;93(1):e70042. https:\/\/doi.org\/10.1111\/aji.70042.","DOI":"10.1111\/aji.70042"},{"issue":"7","key":"8179_CR120","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/jog.15944","volume":"50","author":"H Song","year":"2024","unstructured":"Song H, Cui T, Shi S, Xiao H, Wei A. Effect of anti-thyroid antibodies on recurrent miscarriage: a meta-analysis. J Obstet Gynaecol. 2024;50(7):1095\u2013105. https:\/\/doi.org\/10.1111\/jog.15944.","journal-title":"J Obstet Gynaecol"},{"issue":"6","key":"8179_CR121","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/1358863X17737374","volume":"22","author":"DE Houghton","year":"2017","unstructured":"Houghton DE, Moll S. Antiphospholipid antibodies. Vasc Med. 2017;22(6):545\u201350. https:\/\/doi.org\/10.1177\/1358863X17737374.","journal-title":"Vasc Med"},{"issue":"1","key":"8179_CR122","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12884-025-07471-w","volume":"25","author":"VR Murvai","year":"2025","unstructured":"Murvai VR, Gali\u0219 R, Panaitescu A, Radu CM, Ghitea TC, Trif P, et al. Antiphospholipid syndrome in pregnancy: a comprehensive literature review. BMC Pregnancy Childbirth. 2025;25(1):337. https:\/\/doi.org\/10.1186\/s12884-025-07471-w.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"8179_CR123","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.semarthrit.2019.02.006","volume":"49","author":"J Alijotas-Reig","year":"2019","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Llurba E, Gris JM. Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: maternal-fetal outcomes in a series of 18 cases. Semin Arthritis Rheumatism. 2019;49(2):314\u201318. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.02.006.","journal-title":"Semin Arthritis Rheumatism"},{"issue":"4","key":"8179_CR124","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11239-017-1571-4","volume":"44","author":"M Becarevic","year":"2017","unstructured":"Becarevic M. Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha. J Thromb Thrombolysis. 2017;44(4):565\u201370. https:\/\/doi.org\/10.1007\/s11239-017-1571-4.","journal-title":"J Thromb Thrombolysis"},{"issue":"20","key":"8179_CR125","doi-asserted-by":"publisher","first-page":"10109","DOI":"10.3390\/ijms262010109","volume":"26","author":"L Lapides","year":"2025","unstructured":"Lapides L, Klein M, Varga I, Voller J, Babal P. Clustering of uterine natural killer cells around uterine glands in women with recurrent implantation failure and recurrent pregnancy loss: an immunohistochemical study. IJMS. 2025;26(20):10109. https:\/\/doi.org\/10.3390\/ijms262010109.","journal-title":"IJMS"},{"issue":"4","key":"8179_CR126","doi-asserted-by":"publisher","first-page":"248","DOI":"10.18502\/jri.v24i4.14152","volume":"24","author":"N Singh","year":"2023","unstructured":"Singh N, Dogra Y, Kumar P, Mathur S, Sharma A, Patel G. Establishment of Cut-off values for uterine and peripheral blood natural killer cells during the Peri-implantation period in fertile controls and women with unexplained recurrent implantation failure. JRI. 2023;24(4):248\u201356. https:\/\/doi.org\/10.18502\/jri.v24i4.14152.","journal-title":"JRI"},{"issue":"3","key":"8179_CR127","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.clim.2009.08.009","volume":"133","author":"LP Jin","year":"2009","unstructured":"Jin LP, Chen Q-Y, Zhang T, Guo P-F, Li D-J. The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage. Clin Immunol. 2009;133(3):402\u201310. https:\/\/doi.org\/10.1016\/j.clim.2009.08.009.","journal-title":"Clin Immunol"},{"issue":"6","key":"8179_CR128","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.fertnstert.2009.11.020","volume":"94","author":"S Mei","year":"2010","unstructured":"Mei S, Tan J, Chen H, Chen Y, Zhang J. Changes of CD4+CD25high regulatory T cells and FOXP3 expression in unexplained recurrent spontaneous abortion patients. Fertil Steril. 2010;94(6):2244\u201347. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.11.020.","journal-title":"Fertil Steril"},{"issue":"4","key":"8179_CR129","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.4049\/jimmunol.1203425","volume":"192","author":"MR Du","year":"2014","unstructured":"Du MR, Guo P-F, Piao H-L, Wang S-C, Sun C, Jin L-P, et al. Embryonic trophoblasts induce decidual regulatory T cell differentiation and maternal\u2013fetal tolerance through thymic stromal lymphopoietin instructing dendritic cells. J Immunol. 2014;192(4):1502\u201311. https:\/\/doi.org\/10.4049\/jimmunol.1203425.","journal-title":"J Immunol"},{"issue":"11","key":"8179_CR130","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1111\/jog.13076","volume":"42","author":"W Hou","year":"2016","unstructured":"Hou W, Li Z, Li Y, Fang L, Li J, Huang J, et al. Correlation between protein expression of FOXP3 and level of FOXP3 promoter methylation in recurrent spontaneous abortion. J Obstet Gynaecol. 2016;42(11):1439\u201344. https:\/\/doi.org\/10.1111\/jog.13076.","journal-title":"J Obstet Gynaecol"},{"key":"8179_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2019.04.003","volume":"81","author":"X Hu","year":"2019","unstructured":"Hu X, Wang Y, Mor G, Liao A. Forkhead box P3 is selectively expressed in human trophoblasts and decreased in recurrent pregnancy loss. Placenta. 2019;81:1\u20138. https:\/\/doi.org\/10.1016\/j.placenta.2019.04.003.","journal-title":"Placenta"},{"issue":"4","key":"8179_CR132","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1084\/jem.182.4.1143","volume":"182","author":"EK Haddad","year":"1995","unstructured":"Haddad EK, Duclos AJ, Baines MG. Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J Exp Med. 1995;182(4):1143\u201351. https:\/\/doi.org\/10.1084\/jem.182.4.1143.","journal-title":"J Exp Med"},{"issue":"10","key":"8179_CR133","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.4049\/jimmunol.158.10.4886","volume":"158","author":"EK Haddad","year":"1997","unstructured":"Haddad EK, Duclos AJ, Lapp WS, Baines MG. Early embryo loss is associated with the prior expression of macrophage activation markers in the decidua. J Immunol. 1997;158(10):4886\u201392. https:\/\/doi.org\/10.4049\/jimmunol.158.10.4886.","journal-title":"J Immunol"},{"issue":"1","key":"8179_CR134","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1006\/cimm.1997.1199","volume":"181","author":"EK Haddad","year":"1997","unstructured":"Haddad EK, Duclos AJ, Antecka E, Lapp WS, Baines MG. Role of interferon-\u03b3 in the priming of decidual macrophages for nitric oxide production and early pregnancy loss. Cellular Immunol. 1997;181(1):68\u201375. https:\/\/doi.org\/10.1006\/cimm.1997.1199.","journal-title":"Cellular Immunol"},{"issue":"1","key":"8179_CR135","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1600-0897.1998.tb00333.x","volume":"39","author":"RG Lea","year":"1998","unstructured":"Lea RG, McIntyre S, Baird JD, Clark DA. Tumor necrosis factor-\u03b1 mRNA-positive cells in spontaneous resorption in rodents. Am J Rep Immunol. 1998;39(1):50\u201357. https:\/\/doi.org\/10.1111\/j.1600-0897.1998.tb00333.x.","journal-title":"Am J Rep Immunol"},{"issue":"1\u20132","key":"8179_CR136","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jri.2011.08.004","volume":"92","author":"WJ Wang","year":"2011","unstructured":"Wang WJ, Hao CF, Lin QD. Dysregulation of macrophage activation by decidual regulatory T cells in unexplained recurrent miscarriage patients. J Reprod Immunol. 2011;92(1\u20132):97\u2013102. https:\/\/doi.org\/10.1016\/j.jri.2011.08.004.","journal-title":"J Reprod Immunol"},{"key":"8179_CR137","doi-asserted-by":"publisher","first-page":"782792","DOI":"10.3389\/fimmu.2021.782792","volume":"12","author":"D Zhu","year":"2021","unstructured":"Zhu D, Zou H, Liu J, Wang J, Ma C, Yin J, et al. Inhibition of HMGB1 ameliorates the maternal-fetal interface destruction in unexplained recurrent spontaneous abortion by suppressing pyroptosis activation. Front Immunol. 2021;12:782792. https:\/\/doi.org\/10.3389\/fimmu.2021.782792.","journal-title":"Front Immunol"},{"issue":"17","key":"8179_CR138","doi-asserted-by":"publisher","first-page":"7216","DOI":"10.7150\/thno.78467","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, Wang H, Luo J, Xie T, Mor G, Liao A. Decorin promotes decidual M1-like macrophage polarization via mitochondrial dysfunction resulting in recurrent pregnancy loss. Theranostics. 2022;12(17):7216\u201336. https:\/\/doi.org\/10.7150\/thno.78467.","journal-title":"Theranostics"},{"key":"8179_CR139","first-page":"114838","volume-title":"Compromised adenosine-A2AR axis contributes to recurrent spontaneous abortion by promoting proinflammatory macrophage polarization","author":"X Gao","year":"2025","unstructured":"Gao X, et al. Compromised adenosine-A2AR axis contributes to recurrent spontaneous abortion by promoting proinflammatory macrophage polarization. Vol. 158. Int Immunopharmacol; 2025. p. 114838."},{"issue":"1","key":"8179_CR140","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/biolre\/ioae041","volume":"111","author":"H Wang","year":"2024","unstructured":"Wang H, Wang L, Gong G, Lin X, Luo J, Liu C, et al. Interleukin-10: a novel metabolic inducer of macrophage differentiation and subsequently contributing to improved pregnancy outcomes of mice by orchestrating oxidative phosphorylation metabolismdagger. Biol Reproduction. 2024;111(1):76\u201391. https:\/\/doi.org\/10.1093\/biolre\/ioae041.","journal-title":"Biol Reproduction"},{"key":"8179_CR141","doi-asserted-by":"publisher","unstructured":"Zhao SJ, Hu X-H, Lin X-X, Zhang Y-J, Wang J, Wang H, et al. IL-27\/Blimp-1 axis regulates the differentiation and function of Tim-3+ Tregs during early pregnancy. JCI Insight. 2024;9(16). https:\/\/doi.org\/10.1172\/jci.insight.179233.","DOI":"10.1172\/jci.insight.179233"},{"issue":"1","key":"8179_CR142","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/1744666X.2025.2612589","volume":"22","author":"G Aldabie","year":"2026","unstructured":"Aldabie G, Almarzooqi A, Aljohani R, Altawash M, Alkadi A, Khamashta M. Navigating obstetric antiphospholipid syndrome: pathophysiology, diagnosis, and therapeutic advances. Expert Rev Clin Immunol. 2026;22(1):123\u201334. https:\/\/doi.org\/10.1080\/1744666X.2025.2612589.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"8179_CR143","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1182\/hematology.2024000547","volume":"2024","author":"P Mittal","year":"2024","unstructured":"Mittal P, Sayar Z, Cohen H. Warfarin and heparin monitoring in antiphospholipid syndrome. Hematol Am Soc Hematol Educ Program. 2024;2024(1):192\u201399. https:\/\/doi.org\/10.1182\/hematology.2024000547.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"8179_CR144","doi-asserted-by":"publisher","unstructured":"Xiao H, Zhang F, Wu Y, Lian R, Diao L, Yin T, et al. The Effect of immunotherapy on natural killer cells level\/activity in recurrent pregnancy loss (RPL) patients: a systematic review and meta-analysis. Am J Rep Immunol. 2025;94(1):e70118. https:\/\/doi.org\/10.1111\/aji.70118.","DOI":"10.1111\/aji.70118"},{"key":"8179_CR145","doi-asserted-by":"publisher","unstructured":"Yamaya A, Fukui A, Kawai K, Yano M, Honda H, Nakagawa K, et al. A comparative study of intravenous immunoglobulin and lipid emulsion in patients with reproductive failures associated with NK cell abnormalities. Reprod Med & Biol. 2025;24(1):e12662. https:\/\/doi.org\/10.1002\/rmb2.12662.","DOI":"10.1002\/rmb2.12662"},{"key":"8179_CR146","doi-asserted-by":"publisher","first-page":"104322","DOI":"10.1016\/j.jri.2024.104322","volume":"166","author":"F Mu","year":"2024","unstructured":"Mu F, Huo H, Wang M, Liu L, Wang F. Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss. J Reprod Immunol. 2024;166:104322. https:\/\/doi.org\/10.1016\/j.jri.2024.104322.","journal-title":"J Reprod Immunol"},{"key":"8179_CR147","doi-asserted-by":"publisher","unstructured":"Banjar S, Kadour E, Khoudja R, Ton-Leclerc S, Beauchamp C, Beltempo M, et al. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss. Am J Rep Immunol. 2023;90(2):e13737. https:\/\/doi.org\/10.1111\/aji.13737.","DOI":"10.1111\/aji.13737"},{"key":"8179_CR148","doi-asserted-by":"publisher","unstructured":"D\u2019Ippolito S, Gavi F, Granieri C, De Waure C, Giuliano S, Cosentino F, et al. Efficacy of corticosteroids in patients with recurrent pregnancy loss: a systematic review and meta-analysis. Am J Rep Immunol. 2025;93(1):e70037. https:\/\/doi.org\/10.1111\/aji.70037.","DOI":"10.1111\/aji.70037"},{"key":"8179_CR149","doi-asserted-by":"publisher","first-page":"1569819","DOI":"10.3389\/fmed.2025.1569819","volume":"12","author":"J Lima","year":"2025","unstructured":"Lima J, Guerreiro J, \u00c2ngelo-Dias M, Serra SS, Costa T, Marto N, et al. Efficacy of therapeutic interventions for idiopathic recurrent pregnancy loss: a systematic review and network meta-analysis. Front. Med. 2025;12:1569819. https:\/\/doi.org\/10.3389\/fmed.2025.1569819.","journal-title":"Front. Med"},{"key":"8179_CR150","doi-asserted-by":"publisher","unstructured":"Warhade AD, More A, Anjankar N, Dhamija P, Warhade P. Exploring lymphocyte immunotherapy as a treatment for recurrent miscarriage: a case study of immune system modulation and positive clinical pregnancy rate. J Pharm Bioallied Sci. 2025;17(Suppl 1):S994\u201396. https:\/\/doi.org\/10.4103\/jpbs.jpbs_387_25.","DOI":"10.4103\/jpbs.jpbs_387_25"},{"key":"8179_CR151","doi-asserted-by":"publisher","first-page":"120503","DOI":"10.1016\/j.lfs.2022.120503","volume":"299","author":"A Sarkesh","year":"2022","unstructured":"Sarkesh A, Sorkhabi AD, Ahmadi H, Abdolmohammadi-Vahid S, Parhizkar F, Yousefi M, et al. Allogeneic lymphocytes immunotherapy in female infertility: lessons learned and the road ahead. Life Sci. 2022;299:120503. https:\/\/doi.org\/10.1016\/j.lfs.2022.120503.","journal-title":"Life Sci"},{"issue":"3","key":"8179_CR152","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1055\/s-0044-101609","volume":"78","author":"V Gunther","year":"2018","unstructured":"Gunther V, Alkatout I, Junkers W, Maass N, Ziemann M, G\u00f6rg S, et al. Active immunisation with partner lymphocytes in female patients who want to become pregnant \u2013 current status. Geburtshilfe Frauenheilkd. 2018;78(3):260\u201373. https:\/\/doi.org\/10.1055\/s-0044-101609.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"8179_CR153","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1620\/tjem.2025.J103","volume":"268","author":"S Chen","year":"2026","unstructured":"Chen S, Li Y, Sun C, Yang J, Li S, Feng Q, et al. Anti-TNF-\u03b1 treatment improves the live birth rate and reduces the risk of premature delivery in patients with recurrent spontaneous abortion. The Tohoku J Exp Med. 2026;268(3):405\u201310. https:\/\/doi.org\/10.1620\/tjem.2025.J103.","journal-title":"The Tohoku J Exp Med"},{"issue":"6","key":"8179_CR154","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.3233\/THC-240757","volume":"32","author":"Z Cai","year":"2024","unstructured":"Cai Z, Guo X, Zheng G, Xiang J, Liu L, Lin D, et al. TNF-\u03b1-positive patients with recurrent pregnancy loss: the etiology and management. THC. 2024;32(6):4581\u201391. https:\/\/doi.org\/10.3233\/THC-240757.","journal-title":"THC"},{"issue":"1","key":"8179_CR155","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12884-024-06443-w","volume":"24","author":"W Huang","year":"2024","unstructured":"Huang W, Zhang X, Zhang L, Dai X, Chen H, Xie Q. Anti-tumor necrosis factor-\u03b1 therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review. BMC Pregnancy Childbirth. 2024;24(1):251. https:\/\/doi.org\/10.1186\/s12884-024-06443-w.","journal-title":"BMC Pregnancy Childbirth"},{"key":"8179_CR156","doi-asserted-by":"publisher","unstructured":"Dai FF, Hu M, Zhang Y-W, Zhu R-H, Chen L-P, Li Z-D, et al. TNF- \u03b1 \/anti-TNF- \u03b1 drugs and its effect on pregnancy outcomes. Expert Rev. Mol. Med. 2022;24:e26. https:\/\/doi.org\/10.1017\/erm.2022.18.","DOI":"10.1017\/erm.2022.18"},{"issue":"7","key":"8179_CR157","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/HJH.0000000000004022","volume":"43","author":"P Zhao","year":"2025","unstructured":"Zhao P, Zhang Y, Zhang G, Niu H, Li J, Hao R, et al. Human umbilical cord mesenchymal stem cells improve the pregnancy outcomes of preeclampsia rats via inducing placental angiogenesis. J Educ Chang Hypertens. 2025;43(7):1182\u201390. https:\/\/doi.org\/10.1097\/HJH.0000000000004022.","journal-title":"J Educ Chang Hypertens"},{"issue":"2","key":"8179_CR158","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/biolre\/ioae074","volume":"111","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Zeng F, Sun J. The improvement of inflammatory infiltration and pregnancy outcome in mice with recurrent spontaneous abortion by human amniotic mesenchymal stem cells. Biol Reproduction. 2024;111(2):351\u201360. https:\/\/doi.org\/10.1093\/biolre\/ioae074.","journal-title":"Biol Reproduction"},{"key":"8179_CR159","doi-asserted-by":"publisher","first-page":"103366","DOI":"10.1016\/j.jri.2021.103366","volume":"148","author":"D Zhang","year":"2021","unstructured":"Zhang D, Lin Y, Li Y, Zhao D, Du M. Mesenchymal stem cells enhance Treg immunosuppressive function at the fetal-maternal interface. J Reprod Immunol. 2021;148:103366. https:\/\/doi.org\/10.1016\/j.jri.2021.103366.","journal-title":"J Reprod Immunol"},{"issue":"4","key":"8179_CR160","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/REP-20-0320","volume":"161","author":"A Salek Farrokhi","year":"2021","unstructured":"Salek Farrokhi A, Zarnani A-H, Rezaei Kahmini F, Moazzeni SM. Mesenchymal stem cells induce expansion of regulatory T cells in abortion-prone mice. Reproduction. 2021;161(4):477\u201387. https:\/\/doi.org\/10.1530\/REP-20-0320.","journal-title":"Reproduction"},{"issue":"10","key":"8179_CR161","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.1002\/jcp.29620","volume":"235","author":"F Rezaei Kahmini","year":"2020","unstructured":"Rezaei Kahmini F, Shahgaldi S, Moazzeni SM. Mesenchymal stem cells alter the frequency and cytokine profile of natural killer cells in abortion-prone mice. J Cellular Physiol. 2020;235(10):7214\u201323. https:\/\/doi.org\/10.1002\/jcp.29620.","journal-title":"J Cellular Physiol"},{"issue":"5","key":"8179_CR162","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/kjm2.12178","volume":"36","author":"YJ Xiang","year":"2020","unstructured":"Xiang YJ, Hou Y-Y, Yan H-L, Liu H, Ge Y-X, Chen N, et al. Mesenchymal stem cells-derived exosomes improve pregnancy outcome through inducing maternal tolerance to the allogeneic fetus in abortion-prone mating mouse. The Kaohsiung J Med Scie. 2020;36(5):363\u201370. https:\/\/doi.org\/10.1002\/kjm2.12178.","journal-title":"The Kaohsiung J Med Scie"},{"issue":"12","key":"8179_CR163","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41423-019-0204-6","volume":"16","author":"Y Li","year":"2019","unstructured":"Li Y, Zhang D, Xu L, Dong L, Zheng J, Lin Y, et al. Cell\u2013cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models. Cell Mol Immunol. 2019;16(12):908\u201320. https:\/\/doi.org\/10.1038\/s41423-019-0204-6.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"8179_CR164","doi-asserted-by":"publisher","first-page":"92","DOI":"10.22074\/cellj.2019.5954","volume":"21","author":"F Rezaei","year":"2019","unstructured":"Rezaei F, Moazzeni SM. Comparison of the therapeutic effect of syngeneic, allogeneic, and xenogeneic adipose tissue-derived mesenchymal stem cells on abortion rates in a mouse model. Cell J. 2019;21(1):92\u201398. https:\/\/doi.org\/10.22074\/cellj.2019.5954.","journal-title":"Cell J"},{"key":"8179_CR165","first-page":"26","volume-title":"Mesenchymal stem cells therapy protects fetuses from resorption and induces Th2 type cytokines profile in abortion prone mouse model","author":"A Salek Farrokhi","year":"2018","unstructured":"Salek Farrokhi A, Zarnani AH, Moazzeni SM. Mesenchymal stem cells therapy protects fetuses from resorption and induces Th2 type cytokines profile in abortion prone mouse model. Vol. 47. Transpl Immunol; 2018. p. 26\u201331."},{"issue":"8","key":"8179_CR166","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1933719117737848","volume":"25","author":"B Sadighi-Moghaddam","year":"2018","unstructured":"Sadighi-Moghaddam B, Salek Farrokhi A, Namdar Ahmadabad H, Barati M, Moazzeni SM. Mesenchymal stem cell therapy prevents abortion in CBA\/J \u00d7 DBA\/2 mating. Reprod. Sci. 2018;25(8):1261\u201369. https:\/\/doi.org\/10.1177\/1933719117737848.","journal-title":"Reprod. Sci"},{"key":"8179_CR167","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.placenta.2016.08.089","volume":"47","author":"YH Meng","year":"2016","unstructured":"Meng YH, Zhu X-H, Yan L-Y, Zhang Y, Jin H-Y, Xia X, et al. Bone mesenchymal stem cells improve pregnancy outcome by inducing maternal tolerance to the allogeneic fetus in abortion-prone matings in mouse. Placenta. 2016;47:29\u201336. https:\/\/doi.org\/10.1016\/j.placenta.2016.08.089.","journal-title":"Placenta"},{"issue":"2","key":"8179_CR168","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jri.2010.02.006","volume":"85","author":"T Shima","year":"2010","unstructured":"Shima T, Sasaki Y, Itoh M, Nakashima A, Ishii N, Sugamura K, et al. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol. 2010;85(2):121\u201329. https:\/\/doi.org\/10.1016\/j.jri.2010.02.006.","journal-title":"J Reprod Immunol"},{"issue":"2","key":"8179_CR169","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1152\/physiolgenomics.00103.2022","volume":"55","author":"HC Xie","year":"2023","unstructured":"Xie HC, Wang Z-G, Feng Y-H, Wang J-X, Liu L, Yang X-L, et al. Bone marrow mesenchymal stem cells repress renal transplant immune rejection by facilitating the APRIL phosphorylation to induce regulation B cell production. Physiol Genomics. 2023;55(2):90\u2013100. https:\/\/doi.org\/10.1152\/physiolgenomics.00103.2022.","journal-title":"Physiol Genomics"},{"issue":"3","key":"8179_CR170","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/iju.14757","volume":"29","author":"X Wang","year":"2022","unstructured":"Wang X, Zhou C, Liu J, Mao L, Yang T, Hong X, et al. Administration of adipose stromal vascular fraction attenuates acute rejection in donation after circulatory death rat renal transplantation. Int J Urology. 2022;29(3):266\u201375. https:\/\/doi.org\/10.1111\/iju.14757.","journal-title":"Int J Urology"},{"issue":"1","key":"8179_CR171","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s10753-021-01561-5","volume":"45","author":"X Wu","year":"2022","unstructured":"Wu X, Wang Z, Wang J, Tian X, Cao G, Gu Y, et al. Exosomes secreted by mesenchymal stem cells induce immune tolerance to mouse kidney transplantation via transporting LncRNA DANCR. Inflammation. 2022;45(1):460\u201375. https:\/\/doi.org\/10.1007\/s10753-021-01561-5.","journal-title":"Inflammation"},{"issue":"3","key":"8179_CR172","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.healun.2010.09.012","volume":"30","author":"DA Grove","year":"2011","unstructured":"Grove DA, Xu J, Joodi R, Torres-Gonzales E, Neujahr D, Mora AL, et al. Attenuation of early airway obstruction by mesenchymal stem cells in a murine model of heterotopic tracheal transplantation. The J Heart Lung Transpl. 2011;30(3):341\u201350. https:\/\/doi.org\/10.1016\/j.healun.2010.09.012.","journal-title":"The J Heart Lung Transpl"},{"issue":"5","key":"8179_CR173","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.jtcvs.2013.09.041","volume":"147","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Gillen JR, Harris DA, Kron IL, Murphy MP, Lau CL. Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model. The J Thorac Cardiovasc Surg. 2014;147(5):1668\u201377.e5. https:\/\/doi.org\/10.1016\/j.jtcvs.2013.09.041.","journal-title":"The J Thorac Cardiovasc Surg"},{"issue":"4","key":"8179_CR174","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/sctm.16-0372","volume":"6","author":"DC Chambers","year":"2017","unstructured":"Chambers DC, Enever D, Lawrence S, Sturm MJ, Herrmann R, Yerkovich S, et al. Mesenchymal stromal cell therapy for chronic Lung allograft dysfunction: results of a first-in-man study. STEM Cells Transl Med. 2017;6(4):1152\u201357. https:\/\/doi.org\/10.1002\/sctm.16-0372.","journal-title":"STEM Cells Transl Med"},{"issue":"2","key":"8179_CR175","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/sctm.17-0198","volume":"7","author":"CA Keller","year":"2018","unstructured":"Keller CA, Gonwa TA, Hodge DO, Hei DJ, Centanni JM, Zubair AC. Feasibility, Safety, and tolerance of mesenchymal stem cell therapy for obstructive chronic Lung allograft dysfunction. STEM Cells Transl Med. 2018;7(2):161\u201367. https:\/\/doi.org\/10.1002\/sctm.17-0198.","journal-title":"STEM Cells Transl Med"},{"issue":"12","key":"8179_CR176","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.healun.2024.08.014","volume":"43","author":"D Edstrom","year":"2024","unstructured":"Edstrom D, Niroomand A, Stenlo M, Broberg E, Hirdman G, Ghaidan H, et al. Amniotic fluid-derived mesenchymal stem cells reduce inflammation and improve lung function following transplantation in a porcine model. The J Heart Lung Transpl. 2024;43(12):2018\u201330. https:\/\/doi.org\/10.1016\/j.healun.2024.08.014.","journal-title":"The J Heart Lung Transpl"},{"key":"8179_CR177","first-page":"21","volume-title":"Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1\/IRF3-regulated-IFN-gamma production","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1\/IRF3-regulated-IFN-gamma production. Vol. 238. Immunol Lett; 2021. p. 21\u201328."},{"issue":"1","key":"8179_CR178","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cellimm.2010.04.002","volume":"264","author":"TE Ichim","year":"2010","unstructured":"Ichim TE, Harman RJ, Min W-P, Minev B, Solano F, Rodriguez JP, et al. Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease. Cellular Immunol. 2010;264(1):7\u201317. https:\/\/doi.org\/10.1016\/j.cellimm.2010.04.002.","journal-title":"Cellular Immunol"},{"issue":"1","key":"8179_CR179","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1479-5876-7-29","volume":"7","author":"NH Riordan","year":"2009","unstructured":"Riordan NH, Ichim TE, Min W-P, Wang H, Solano F, Lara F, et al. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med. 2009;7(1):29. https:\/\/doi.org\/10.1186\/1479-5876-7-29.","journal-title":"J Transl Med"},{"key":"8179_CR180","first-page":"116208","volume-title":"Comparative efficacy of mesenchymal stromal cells versus multi-target therapy in systemic lupus erythematosus","author":"J Wang","year":"2026","unstructured":"Wang J, et al. Comparative efficacy of mesenchymal stromal cells versus multi-target therapy in systemic lupus erythematosus. Vol. 172. Int Immunopharmacol; 2026. p. 116208."},{"key":"8179_CR181","doi-asserted-by":"publisher","unstructured":"Hou Z, Yang T, Xu D, Fu J, Tang H, Zhao J, et al. hUC-MSCs loaded collagen scaffold for refractory thin endometrium caused by Asherman syndrome: a double-blind randomized controlled trial. STEM Cells Transl Med. 2025;14(4). https:\/\/doi.org\/10.1093\/stcltm\/szaf011.","DOI":"10.1093\/stcltm\/szaf011"},{"key":"8179_CR182","first-page":"113853","volume-title":"Intranasal delivery of mesenchymal stem cell-derived exosomes ameliorates experimental autoimmune encephalomyelitis","author":"J Wu","year":"2025","unstructured":"Wu J, et al. Intranasal delivery of mesenchymal stem cell-derived exosomes ameliorates experimental autoimmune encephalomyelitis. Vol. 146. Int Immunopharmacol; 2025. p. 113853."},{"issue":"1","key":"8179_CR183","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s11033-024-09433-5","volume":"51","author":"A Mohammadzadeh","year":"2024","unstructured":"Mohammadzadeh A, Lahouty M, Charkhian H, Ghafour AA, Moazzendizaji S, Rezaei J, et al. Human umbilical cord mesenchymal stem cell-derived exosomes alleviate the severity of experimental autoimmune encephalomyelitis and enhance lag-3 expression on foxp3 + CD4 + T cells. Mol Biol Rep. 2024;51(1):522. https:\/\/doi.org\/10.1007\/s11033-024-09433-5.","journal-title":"Mol Biol Rep"},{"key":"8179_CR184","first-page":"268","volume-title":"Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia","author":"Z Li","year":"2019","unstructured":"Li Z, et al. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Vol. 67. Int Immunopharmacol; 2019. p. 268\u201380."},{"issue":"Pt 2","key":"8179_CR185","doi-asserted-by":"publisher","first-page":"113340","DOI":"10.1016\/j.intimp.2024.113340","volume":"143","author":"X Wang","year":"2024","unstructured":"Wang X, Shi T, Jiao Y, Geng Q, Zhao H, Deng T, et al. Human umbilical mesenchymal stem cell-derived exosomes alleviate bone destruction and regulate bone immunity via the aryl hydrocarbon receptor to treat rheumatoid arthritis. Int Immunopharmacol. 2024;143(Pt 2):113340. https:\/\/doi.org\/10.1016\/j.intimp.2024.113340.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"8179_CR186","doi-asserted-by":"publisher","first-page":"112832","DOI":"10.1016\/j.isci.2025.112832","volume":"28","author":"FT Xu","year":"2025","unstructured":"Xu FT, Ling Y, Wei H-X, Meng L, Yin D, Lai Z-H, et al. BMSC exosomes deliver JKAP to restore Th17\/Treg balance via AKT\/ERK, alleviating rheumatoid arthritis. iScience. 2025;28(7):112832. https:\/\/doi.org\/10.1016\/j.isci.2025.112832.","journal-title":"iScience"},{"issue":"3","key":"8179_CR187","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.2337\/db13-0859","volume":"63","author":"MJ Rahman","year":"2014","unstructured":"Rahman MJ, Regn D, Bashratyan R, Dai YD. Exosomes released by islet-derived mesenchymal stem cells trigger autoimmune responses in NOD mice. Diabetes. 2014;63(3):1008\u201320. https:\/\/doi.org\/10.2337\/db13-0859.","journal-title":"Diabetes"},{"issue":"8","key":"8179_CR188","doi-asserted-by":"publisher","first-page":"108695","DOI":"10.4252\/wjsc.v17.i8.108695","volume":"17","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Zeng F-Y, Chen Z-Y, Zhao F, Sun J-L. Advances in mesenchymal stem cell-based therapies for recurrent spontaneous abortion. World J STEM Cells. 2025;17(8):108695. https:\/\/doi.org\/10.4252\/wjsc.v17.i8.108695.","journal-title":"World J STEM Cells"},{"issue":"6","key":"8179_CR189","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s43032-024-01458-2","volume":"31","author":"K Chen","year":"2024","unstructured":"Chen K, Wang H, Zhao X, Wang J, Jin Q, Tong X, et al. A novel method to repair thin endometrium and restore fertility based on menstruation-derived stem cell. Reprod. Sci. 2024;31(6):1662\u201373. https:\/\/doi.org\/10.1007\/s43032-024-01458-2.","journal-title":"Reprod. Sci"},{"key":"8179_CR190","doi-asserted-by":"publisher","unstructured":"Liu L, Zhao G, Fan H, Zhao X, Li P, Wang Z, et al. Mesenchymal stem cells ameliorate Th1-induced pre-eclampsia-like symptoms in mice via the suppression of TNF-\u03b1 expression. PLoS One. 2014;9(2):e88036. https:\/\/doi.org\/10.1371\/journal.pone.0088036.","DOI":"10.1371\/journal.pone.0088036"},{"issue":"1","key":"8179_CR191","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13293-019-0263-5","volume":"10","author":"S Suvakov","year":"2019","unstructured":"Suvakov S, Cubro H, White WM, Butler Tobah YS, Weissgerber TL, Jordan KL, et al. Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia. Biol Sex Differ. 2019;10(1):49. https:\/\/doi.org\/10.1186\/s13293-019-0263-5.","journal-title":"Biol Sex Differ"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08179-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08179-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08179-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:39:52Z","timestamp":1781649592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08179-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":191,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8179"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08179-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This review was supported by Aureum Therapeutics Inc. FSR, JP, GKN, FN and GD are employees\/associates of Aureum Therapeutics Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"751"}}